title: [The effectiveness of psychoeducation in schizophrenic and depressive patients--preliminary report].
abstract: Earlier studies suggest that psychoeducation as a form of psychosocial care is of value in improving the patient's attitude towards mental illness as well as in reducing and delaying the relapse rates of both--psychotic and depressive disorders.
  
  
  OBJECTIVE
  The aim of this study was the evaluation of influence of psychoeducation on clinical symptoms, quality of life and drug attitude in schizophrenic and depressive patients.
  
  
  METHODS
  52 patients, aged 18-50 years, hospitalized in the Department of Psychiatry of Medical Academy in Białystok, were involved in the study. They were randomly assigned into 2 groups: on medication without psychoeducation (12 schizophrenics, 12 depressive patients) and on medication and psychoeducation (16 schizophrenics and 12 depressive patients). The patients were assessed by means of BPRS, BNS, IMHC 2000, Raskin/Covi Scale, DAI-10. The assessment was performed twice--shortly after admission and before discharge from the hospital.
  
  
  RESULTS
  The patients in both groups showed improvement in symptoms and in quality of life. Patients on psychoeducation changed their drug attitude positively significantly more often.
  
  
  CONCLUSIONS
  Knowledge about the positive influence of medication on psychiatric symptoms helps to improve compliance and improves the course of disease.
authors.forename: Regina
authors.initials: R
authors.lastname: Popławska
authors.forename: Andrzej
authors.initials: A
authors.lastname: Czernikiewicz
authors.forename: Agata
authors.initials: A
authors.lastname: Szulc
authors.forename: Beata
authors.initials: B
authors.lastname: Galińska
authors.forename: Beata
authors.initials: B
authors.lastname: Konarzewska
authors.forename: Inessa
authors.initials: I
authors.lastname: Rudnik-Szałaj
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy / Q000379:methods; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology / Q000534:rehabilitation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods; D017060:Patient Satisfaction; D011044:Poland; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D012559:Schizophrenia / Q000188:drug therapy / Q000534:rehabilitation*; D012565:Schizophrenic Psychology; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents